211 related articles for article (PubMed ID: 22198047)
21. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve.
Coppey LJ; Davidson EP; Dunlap JA; Lund DD; Yorek MA
Int J Exp Diabetes Res; 2000; 1(2):131-43. PubMed ID: 11469397
[TBL] [Abstract][Full Text] [Related]
22. Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse.
Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Lund DD; Adebara ET; Yorek MA
Diabetes Obes Metab; 2008 Jan; 10(1):64-74. PubMed ID: 17970755
[TBL] [Abstract][Full Text] [Related]
23. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
[TBL] [Abstract][Full Text] [Related]
24. Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes.
Cotter MA; Jack AM; Cameron NE
Clin Sci (Lond); 2002 Sep; 103(3):311-21. PubMed ID: 12193157
[TBL] [Abstract][Full Text] [Related]
25. Na+/H+ exchanger 1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats.
Lupachyk S; Watcho P; Shevalye H; Vareniuk I; Obrosov A; Obrosova IG; Yorek MA
Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E396-404. PubMed ID: 23736542
[TBL] [Abstract][Full Text] [Related]
26. Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity.
Davidson EP; Coppey LJ; Dake B; Yorek MA
J Obes; 2011; 2011():. PubMed ID: 20847891
[TBL] [Abstract][Full Text] [Related]
27. Effect of Early and Late Interventions with Dietary Oils on Vascular and Neural Complications in a Type 2 Diabetic Rat Model.
Coppey L; Davidson E; Shevalye H; Obrosov A; Yorek M
J Diabetes Res; 2019; 2019():5020465. PubMed ID: 31485451
[TBL] [Abstract][Full Text] [Related]
28. Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats.
Davidson EP; Coppey LJ; Shevalye H; Obrosov A; Yorek MA
J Diabetes Res; 2018; 2018():2967127. PubMed ID: 30057911
[TBL] [Abstract][Full Text] [Related]
29. Vascular and Neural Complications in Type 2 Diabetic Rats: Improvement by Sacubitril/Valsartan Greater Than Valsartan Alone.
Davidson EP; Coppey LJ; Shevalye H; Obrosov A; Yorek MA
Diabetes; 2018 Aug; 67(8):1616-1626. PubMed ID: 29941448
[TBL] [Abstract][Full Text] [Related]
30. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.
Obrosova IG; Drel VR; Oltman CL; Mashtalir N; Tibrewala J; Groves JT; Yorek MA
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1645-55. PubMed ID: 17911342
[TBL] [Abstract][Full Text] [Related]
31. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
Diabetes Metab Res Rev; 2002; 18(1):49-56. PubMed ID: 11921418
[TBL] [Abstract][Full Text] [Related]
32. Effect of fidarestat and alpha-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction.
Yorek MA; Coppey LJ; Gellett JS; Davidson EP; Lund DD
Exp Diabesity Res; 2004; 5(2):123-35. PubMed ID: 15203883
[TBL] [Abstract][Full Text] [Related]
33. Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.
Yorek MS; Obrosov A; Shevalye H; Coppey LJ; Kardon RH; Yorek MA
Neuropharmacology; 2017 Apr; 116():122-131. PubMed ID: 28025096
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin.
Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Lund DD; Yorek MA
Obesity (Silver Spring); 2008 Jan; 16(1):82-9. PubMed ID: 18223617
[TBL] [Abstract][Full Text] [Related]
35. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
36. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
[TBL] [Abstract][Full Text] [Related]
37. In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat.
Hubner RA; Kubota E; Casley DJ; Johnston CI; Burrell LM
J Hypertens; 2001 May; 19(5):941-6. PubMed ID: 11393678
[TBL] [Abstract][Full Text] [Related]
38. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
39. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation.
Coppey LJ; Gellett JS; Davidson EP; Yorek MA
Free Radic Res; 2003 Jan; 37(1):33-40. PubMed ID: 12653215
[TBL] [Abstract][Full Text] [Related]
40. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function.
Yorek MA; Coppey LJ; Gellett JS; Davidson EP; Bing X; Lund DD; Dillon JS
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1067-75. PubMed ID: 12376336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
